Seventy-six patients took part in a randomized, comparative study of the efficacy of buflomedil hydrochloride and dihydrogenated ergot alkaloids in the treatment of senile dementia associated with cerebrovascular insufficiency. Efficacy was assessed by the patients' performance in four psychometric tests. The results showed that a trend in favour of the buflomedil group in three of the tests became statistically significant in the fourth. Both drugs appeared to be safe, causing no marked adverse reactions. In conclusion, buflomedil is as effective or more effective than dihydrogenated ergot alkaloids in the treatment of senile dementia associated with cerebrovascular insufficiency and could prove a valuable addition to long-term therapy if further studies support the trend shown in this study.
Get full access to this article
View all access options for this article.
References
1.
AmbroziLNeumayerE (1971) Zerebrovaskulare Insuffizienz und Hirnleistung. Wiener Klinische Wochenschrift11, 188.
2.
BogerJ (1975) Beitrag zur Untersuchung der Hirnleistung und manuellen Feinmotorik im Altersgang. Aktuel. Gerontol. 2, 249.
3.
CloarecM (1977) Traitement des troubles circulatoires provoques par l'amantadine. Med. Practicienne3, 86.
4.
DavidH AHartleyH OPearsonE S (1954) The distribution of the ratio, in a single normal sample, of range to standard deviation. Biometrika41, 482.
5.
GenesioM A DemechelisSanzM Cid (1981) Evaluation of buflomedil in geriatric patients suffering from vascular cerebral insufficiency. Angiology32, 717.
6.
DormandyJ AErnstE (1981) Effects of buflomedil on erythrocyte deformability. Angiology32, 714.
7.
DugourA M (1981) Enfermedad demencial: Posibilidad terapeutica del clorhidrato de buflomedil. Dia Medico53, 98.
8.
EnrichBSchosserRBeyerJMartinEMessmerK (1981) Influence of buflomedil on total 02 consumption, regional blood flow and tissue p02. In: Microcirculation and Ischemic Vascular Diseases: Advances in Diagnosis and Therapy. Proceeding of Congress, Federal Republic of Germany, November 28–29, 1980, Munich. Ed.: MessmerK., p. 233. New York. Academy Professional Information Services, Inc.
9.
FagrellBHermanssonI T (1981) The effect of buflomedil on skin microcirculation in patients with severe skin ischaemia. In: Microcirculation and Ischemic Vascular Diseases: Advances in Diagnosis and Therapy. Proceedings of Congress, Munich, Federal Republic of Germany, November 28–29, 1980. Academy Professional Information Services, Inc.
10.
HoperJKesslerM (1981) Influence of buflomedil on oxygen uptake rate of liver tissue. In: Microcirculation and Ischemic Vascular Diseases: Advances in Diagnosis and Therapy. Proceedings of Congress, Munich, Federal Republic of Germany, November 28–29, 1980. Academy Professional Information Services, Inc.
11.
IngvarD H (1975) Brain work in presenile dementia and in chronic schizophrenia. In: Brain Work, Proceedings of the Alfred Benzon Symposium VIII, Eds.: IngvarD HLassonN A, p. 478. Copenhagen: Munksgaard.
12.
IngvarD HGustafsonL (1970) Regional cerebral blood flow in organic dementia with early onset. Acta Neurologica Scandinavica46, (Supplement 43), 42.
13.
KatzmanR (1976) The prevalence and malignancy of Alzheimer disease, a major killer. Archives of Neurology33, 217.
14.
KuglerJOswalkW DHerzfeldUSeusRPingelJWelzelD (1978) Langzeittherapie altersbedingter Insuffizienzerscheinungen des Gehirns. Deutsche Medizinische Wochenschrift103, 456.
15.
Pacheco e SilvaAde AlmeidaS Maria Landi (1981) Double-blind comparative study of cinarizine and buflomedil in patients suffering from cerebrovascular insufficiency. Angiology32, 728.
16.
RothMMyersD H (1969) The diagnosis of dementia. British Journal of Hospital Medicine2, 705.
17.
RoubicekJGeigerCAbtK (1972) An ergot alkaloid preparation (Hydergine) in geriatric therapy. Journal of the American Geriatric Society20, (5), 222.
18.
SokoloffL (1975) Cerebral circulation and metabolism in the aged. Psychoparmacology Bulletin11, No. 4, 45.
19.
Sunder-PlassmannLMessmerKBeckerH M (1981) Tissue p02 and transcutaneous p02 as guidelines in experimental and clinical drug evaluation. Angiology32, 686.
20.
ThibaultA (1974) A double-blind evaluation of ‘Hydergine‘ and placebo in the treatment of patients with organic brain syndrome and cerebral arteriosclerosis in a nursing home. Current Medical Research and Opinion2, 482.
21.
TrubesteinGDuongQ D (1981) Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease. Angiology32, 705.
22.
WechslerD (1944) The Measurement of Adult Intelligence, 3rd ed., p. 147Baltimore: Williams & Wilkins.
WurzingerL J (1981) Effects of buflomedil on spontaneous and adrenalin-induced platelet aggregation in vitro and after intravenous application under heparin anticoagulation. In: Microcirculation and Ischemic Vascular Diseases: Advances in Diagnosis and Therapy, Proceedings of Congress, Munich, Federal Republic of Germany, November 28–29, 1980. New York: Academy Professional Information Services, Inc. Ed.: MessmerK., p. 103.
